Skip to content

Comparative evaluation of renal tumors by contrast-enhanced US with Sonazoid and SonoVue

Comparative evaluation of renal tumors by contrast-enhanced US with Sonazoid and SonoVue

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055464
Enrollment
Unknown
Registered
2022-01-10
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumor

Interventions

Index test:Showdroon&#32
Sonovel&#32
ultrasound&#32
machine.

Sponsors

The Third Medical Center of Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-85 years; 2. Conventional ultrasonography indicates that the kidney has clear lesions with renal parenchyma around it, and pathological results can be obtained from the lesions and renal parenchyma; 3. If the patients are women, they should be non-pregnant and lactating women; 4. Patients who are going to undergo needle biopsy or lesion resection; 5. Patients voluntarily joined the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Known allergy to any component of Sonovue or Sonazoid; 2. The patient has a history of allergy to eggs or egg products (ie, systemic rash, dyspnea, swelling of the mouth or throat, hypotension or shock, etc.); 3. Patients with severe heart disease or severe lung disease; 4. Patients who are deemed unsuitable to participate in this study according to the investigator's judgment.

Design outcomes

Primary

MeasureTime frame
Perfusion;Pseudocapsule sign;Entrance mode;Intensity at peak time;Homogeneity;sensitivity, specificity, accuracy;

Secondary

MeasureTime frame
Margin;Shape;Echogenicity;Blood flow;

Countries

China

Contacts

Public ContactGao Yongyan

The Third Medical Center of Chinese People's Liberation Army General Hospital

gaoyongyan7@163.com+86 18910900177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026